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Background. Although volatile anaesthetics afford protection against bronchospasm, their
potential to reverse a sustained constriction of hyperreactive airways has not been character-
ized. Accordingly, we investigated the ability of halothane, iso¯urane, sevo¯urane and des¯ur-
ane to reverse lung constriction induced by prolonged stimulation of the muscarinic receptors
in guinea pigs sensitized to ovalbumin.
Methods. Pulmonary input impedance (ZL) was measured using forced oscillations in ®ve
groups of ovalbumin-sensitized, mechanically ventilated guinea pigs. ZL was measured under
baseline conditions, during steady-state bronchoconstriction induced by an i.v. infusion of
methacholine (MCh), and after administration of one of the volatile agents at 1 MAC after the
induction of a steady-state bronchoconstriction. Airway resistance (Raw), and parenchymal
tissue resistive and elastic coef®cients were extracted from ZL by model ®tting.
Results. All four volatile agents exhibited an initial relaxation of the MCh-induced airway
constriction followed by gradual increases in Raw. The bronchodilatory effect of iso¯urane was
the most potent (±28.9 (SE 5.5)% at 2 min, P<0.05) and lasted longest (7 min); sevo¯urane and
halothane had shorter and more moderate effects (±21.1 (3.9)%, P<0.05, and ±6.1 (1.7)%,
P<0.05, respectively, at 1 min). Des¯urane caused highly variable changes in Raw, with a
tendency to enhance airway tone.
Conclusions. Volatile agents can reverse sustained MCh-induced airway constriction only
transiently in sensitized guinea pigs. Iso¯urane proved most bene®cial in temporally improving
lung function in the presence of a severe constriction of allergic in¯amed airways. Des¯urane
displayed potential to induce further airway constriction.
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There has recently been a worldwide increase in the
recognition of patients with bronchial hyperreactivity
(BHR) who, with an elevated perioperative respiratory
morbidity, pose challenges to the anaesthetist.1 2 The fact
that most anaesthetic agents have bronchoactive properties
compels anaesthetists to select an optimal anaesthetic
management in this population, which is at high risk of
enhanced lung constriction.
Among the anaesthetic drugs, volatile inhalation agents
are expected to possess bene®cial properties, since numer-
ous studies have demonstrated their potential to prevent
lung constriction.3±12 However, only a few studies have
addressed the ability of volatile agents to reverse a sustained
lung constriction.7 13 14 Brown and colleagues7 and
Hashimoto and colleagues14 made use of a continuous i.v.
infusion of histamine to induce steady-state bronchocon-
striction, and described dose-dependent gradual increases in
airway diameter during the administration of halothane,7 14
en¯urane,14 iso¯urane7 and sevo¯urane.14 Nevertheless,
tachyphylaxis may have been involved in the observed
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airway dilation, as the level of lung constriction has been
shown to decrease during prolonged infusion of histamine.15
Ishikawa and colleagues13 infused methacholine (MCh) to
generate steady-state changes in lung mechanics without
separating airway and parenchymal effects. Since the MCh
infusion was likely to generate both airway and parench-
ymal constriction in their animals,16 changes in airway
mechanics could not be characterized. Additionally, all
these previous studies on the preventive or reversal effects
of volatile anaesthetics involved animals with normal lung
reactivity. Thus, the effects of these inhalation agents on
constricted sensitized airways have not yet been investi-
gated.
We used an animal model of BHR to characterize the
ability of the routinely used volatile inhalation agents
(halothane, iso¯urane, sevo¯urane and des¯urane) to
reverse lung constriction induced by prolonged stimulation
of muscarinic receptors. Since BHR affects primarily the
airways, a forced oscillation technique at low
frequencies12 15±20 was applied to separate airway and
tissue properties for an accurate description of changes in
the lungs.
Methods
Sensitization
To induce BHR, young male, pathogen-free Hartley guinea
pigs weighing 250±350 g were actively sensitized by daily
exposure to aerosolized ovalbumin (10 mg ml±1 in sterile
sodium chloride 0.9% solution for 5 min) for a period of 1
week.21 22 In order to avoid the development of tolerance to
ovalbumin, the animals were fed with food free of egg
proteins, and were kept under environmental conditions that
were as stable as possible. Food and water were available ad
libitum.
Animal preparation
Guinea pigs were anaesthetized with urethane 2 g kg±1 i.p.
This dose produces deep anaesthesia for 8±10 h.23 A
tracheostomy was then performed and the guinea pigs were
mechanically ventilated (Model 683, Harvard Apparatus,
South Natick, MA, USA) with a constant tidal volume of 1
ml 100 g±1 and a frequency of 50±60 min±1 at an FIO2 of 0.3
in air. The femoral artery was cannulated with a silastic
catheter (28-gauge catheter, Portex, Hythe, UK) for con-
tinuous haemodynamic monitoring (arterial pressure and
heart rate) with a calibrated pressure transducer (model 156
PC 06-GW2, Honeywell, ZuÈrich, Switzerland). A similar
silastic catheter was inserted into the jugular vein for drug
delivery. Fentanyl was administered at 2 mg kg±1 h±1 to
ensure adequate analgesia. A thoracotomy was performed
with sternal splitting and the chest was largely retracted. A
positive end-expiratory pressure of 2.5 cm H2O was applied
to avoid lung collapse.
Airway pressure was measured continuously using a
calibrated pressure transducer (Validyne DP 45, Northridge,
CA, USA). Rectal temperature was monitored with a
temperature sensor (Thermalert, model TH-8, Physitemp,
Clifton, NJ, USA) and maintained at 37 (0.5)°C with a
heating pad (Miostar, ZuÈrich, Switzerland). Airway and
arterial pressures, heart rate and rectal temperature were
displayed and stored on a microcomputer at a sampling rate
of 50 Hz via an analogue/digital interface converter
(Biopac, Santa Barbara, CA, USA).
Arterial blood samples were analysed radiometrically
(model 505, Acid Base Laboratory, Copenhagen, Denmark)
before each MCh challenge. End-tidal concentrations of
oxygen, carbon dioxide and volatile agents were monitored
throughout the study (UltimaTM, Datex/Instrumentarium,
Helsinki, Finland). The volatile agents were administered
by a vaporizer connected to the ventilator inlet. Target end-
tidal concentrations of volatile agents were achieved in a
short period of time (within 1 min) because of the low dead
space of the ventilation circuit, the high ventilation rate in
guinea pigs, and the relatively high fresh gas ¯ow. The
vaporizer was adjusted if necessary to ensure a constant 1
MAC end-tidal volatile anaesthetic concentration.
Measurement of airway and tissue mechanics
The respective contributions of the airway and tissue
mechanical properties to total lung resistance were esti-
mated by the forced oscillation technique by measuring
pulmonary input impedance (ZL), as described in detail
previously.12 17 Brie¯y, the tracheal cannula was connected
from the respirator to a loudspeaker-in-box system at end-
expiration. The loudspeaker generated a small-amplitude
pseudo-random signal with frequency components of 0.5±
21 Hz through a polyethylene wave tube with known
geometry. Two identical pressure transducers were used to
measure the lateral pressures at the loudspeaker (P1) and at
the tracheal end (P2) of the wave tube. ZL was calculated as
the load impedance of the wave tube using fast Fourier
transformation:
ZL = Zo sinh(gL)/[(P1/P2) ± cosh(gL)]
where L is the length, Zo is the characteristic impedance and
g is the complex propagation wave number of the wave tube.
The latter two parameters are determined by the geometrical
data and the material constants of the tube wall and the air.
To separate the airway and tissue mechanics, a model
containing a frequency-independent airway resistance
(Raw) and inertance (Iaw) in series with a constant-phase
tissue model16 including parenchymal damping (G) and
elastance (H) was ®tted to the ZL spectra by minimizing the
differences between the measured and modelled impedance
values:
ZL= Raw + jwIaw + (G±jH)/wa
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where j is the imaginary unit, w is the angular frequency
(2pf), and a=2/p arctan(H/G).
Experimental protocol
Fifty-two guinea pigs were included in the study. No
sensitization was performed on eight, while the other 43
were exposed to ovalbumin. After surgery, a period of 5±10
min was allowed to establish steady-state conditions, and
four baseline ZL recordings were collected. The i.v. MCh
infusion was then started (1 mg kg±1 min±1). Ten min later,
when the constriction was expected to be in a steady state,
ZL was measured at 1 min intervals for 5±10 min, until four
successive measurements revealed the same lung mechan-
ical condition. If the estimated airway response was lower
than 25%, the rate of infusion of MCh was increased to 2 or
4 mg kg±1 min±1 and ZL was collected for another 10 min.
The guinea pigs were then randomly assigned to receive no
volatile anaesthetic (n=5) or halothane (n=10), sevo¯urane
(n=7), iso¯urane (n=10) or des¯urane (n=7) at a concentra-
tion of 1 MAC. MAC values for the guinea pigs were
established as 1% for halothane,24 1.2% for iso¯urane,24
6.4% for des¯urane25 and 2% for sevo¯urane.26 Changes in
lung mechanics during gas administration were followed by
measuring ZL at 1 min intervals for 10 min. Administration
of volatile agent was then terminated and a period of 8 min
was allowed before another four ZL data sets were
collected, while MCh was maintained.
To ensure the ef®cacy of the sensitization procedure, a
new set of control ZL measurements were collected after the
MCh infusion, and ovalbumin 0.2 mg was injected i.v. The
resultant effect of the antigen±antibody reaction on the
early-phase lung response was estimated by collecting ZL
data for a further 4 min.
Bronchoalveolar lavage (BAL) ¯uid was collected at the
end of the experiment by introducing normal saline under a
hydrostatic pressure of 20 cm H2O into the trachea. The
extracted 10±20 ml BAL ¯uid was immediately centrifuged
for 10 min at 1600 rpm while a temperature of 4°C was
maintained. The sedimented cells were mixed with 1 ml of
phosphate-buffered saline. Total and differential cell counts
were performed on cytospin slides, standard morphologic
criteria being applied.
BHR was assessed by comparing the changes in lung
mechanical parameters during infusion of MCh 1 mg kg±1
min±1 in non-sensitized animals (n=8) and in those under-
going the sensitization procedure and receiving the same
dose of MCh (n=19).
ZL data collected under baseline conditions and those
measured during steady-state constriction were averaged
and used for model ®tting. Individual ZL data were ®tted
with the model during administration of the volatile agent,
and following ovalbumin challenge. In the latter case, peak
response in Raw was used for further analyses.
Statistical analysis
Scatters in the parameters were expressed in SE values. The
Kolmogorov±Smirnov test was used to test data for
normality. Changes in the lung mechanical parameters in
response to MCh or ovalbumin in naive and sensitized
animals were compared using t-tests. The temporal effects
of the volatile agents were assessed by using repeated-
measures one-way analysis of variance (ANOVA). Another
one-way ANOVA was applied to compare the effects of the
different volatile agents at a given time point. Pairwise
comparisons were performed using Student±Newman±
Keuls multiple comparison procedures. Statistical signi®-
cance was set at P<0.05.
Results
Sensitization induces BHR
Among the 43 sensitized animals, daily exposure to an
ovalbumin aerosol induced respiratory distress in six guinea
pigs on day 7, necessitating the suspension of ovalbumin
administration, and oxygen and salbutamol administration.
Despite this respiratory support, four guinea pigs died
during the sensitization period; these animals were excluded
from the protocol groups.
Analyses of BAL revealed that sensitization resulted in
statistically signi®cant increases in the relative numbers of
neutrophils (102 (14)% compared with those in naive
animals (52 (14)%, P<0.05). The number of monocytes/
macrophages was also higher in sensitized than untreated
animals (158 (29) vs 101 (8), P<0.05).
In sensitized animals, baseline lung mechanical param-
eters were similar to those observed in the non-sensitized
animals (31.5 (1.7) vs 31.9 (1.2) cm H2O s litre
±1 for Raw,
232 (11) vs 242 (10) cm H2O litre
±1 for G, and 1084 (70) vs
994 (42) cm H2O litre
±1 for H. A MCh infusion 1 mg kg±1
Table 1 Relative changes in airway resistance (Raw), inertance (Iaw), parenchymal damping (G) and elastance (H) during methacholine (MCh)-induced
steady-state constriction before the onset of the volatile agent
Halothane Iso¯urane Des¯urane Sevo¯urane MCh alone One-way
(n=10) (n=10) (n=7) (n=7) (n=5) ANOVA
Raw (%) 130 (28) 90 (24) 122 (38) 159 (56) 138 (43) P=0.31
Iaw (%) ±40 (10) ±22 (7) ±48 (17) ±44 (31) ±47 (20) P=0.77
G (%) 56 (19) 31 (9) 46 (13) 82 (40) 114 (52) P=0.51
H (%) 15 (7) 12 (4) 8 (6) 13 (8) 23 (10) P=0.67
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min±1 into animals sensitized with ovalbumin induced
signi®cantly greater elevations in Raw (150 (28)%) and G
(65 (16)%) than those in the non-sensitized group (16 (8)%,
P=0.005, and 1.4% (3.1)%, P=0.01). H increased only
slightly in both groups of guinea pigs (21 (6)% vs 7 (6)%,
P=0.17). I.V. administration of ovalbumin 0.2 mg induced
an early-phase type response only in the sensitized animals.
This response was observed in all the sensitized animals
included in the present study, with a severe reaction leading
to complete airway obstruction and circulatory collapse in
three animals. In the animals in which data collection was
completed, peak increases in Raw, G and H were 418
(87)%, 831 (297)% and 258 (92)%, respectively.
Effects of methacholine
Similarly to previous ®ndings,12 17 the i.v. MCh infusion
induced marked and statistically signi®cant elevations in
Raw and G, while the increases in H were smaller.
Furthermore, there was no difference between the protocol
groups in the magnitude of the MCh-induced changes in
lung mechanical parameters (Table 1).
Effects of volatile agents
Figure 1 illustrates the effects of the volatile anaesthetic
agents on MCh-induced increases in Raw. All four volatile
anaesthetics caused statistically signi®cant decreases in
Raw after 1 min administration. Iso¯urane was the most
potent in reversing the MCh-induced bronchospasm.
Moreover, the bronchodilatory effect of iso¯urane was the
most marked (±28.9 (5.5)% at 2 min, P<0.05) and lasted the
longest (7 min). Sevo¯urane also decreased Raw markedly
(21.1 (3.9)% at 1 min, P<0.05) with a bronchodilatory
duration of only 2 min. A bronchodilatory effect was
observed for halothane (6.1 (1.7)%, P<0.05) and des¯urane
(12.2 (9.7)%, P<0.05) only after the ®rst min of inhalation.
After this initial bronchodilatory effect, a trend was
observed in Raw to increase for all gases. Signi®cant
increases in Raw were observed after 5 min for halothane, 8
min for sevo¯urane and 10 min for iso¯urane. Prolonged
administration of des¯urane caused highly variable changes
in Raw: marked increases in Raw were observed in four
guinea pigs, whereas in the other animals the long-term
changes in Raw followed a qualitatively similar trend to
those observed for the other gases. On termination of
inhalation agents, MCh induced a further increase in Raw in
those animals that had received halothane, iso¯urane or
sevo¯urane.
Figures 2 and 3 demonstrate the effects of these volatile
anaesthetics on the tissue resistive and elastic properties,
respectively. Changes in G during volatile agent adminis-
tration followed patterns similar to those observed in Raw,
but the effects were smaller, and hence a statistically
signi®cant difference was not detected. In general, the
volatile agents had minor effects on H.
Fig 1 Changes in airway resistance (Raw) during volatile agent
administration. Values (mean and SE) are represented as relative changes
from the plateau constriction induced by continuous infusion of
methacholine (MCh). *P<0.05 vs the Raw value obtained at the MCh
plateau for a given volatile anesthetic. #P<0.05 vs the Raw value
obtained in the control group at the corresponding time point.
Fig 2 Changes in tissue damping coef®cient (G) during volatile agent
administration. Values (mean and SE) are represented as relative changes
from the plateau constriction induced by the continuous infusion of
methacholine (MCh).
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Discussion
The present investigation related the ability of routinely
used volatile anaesthetic agents to reverse the bronchocon-
striction induced by stimulation of muscarinic receptors in
the presence of BHR. An initial bronchodilatory effect
followed by a gradual deterioration in airway function was
observed during the administration of halothane, sevo¯ur-
ane or iso¯urane. Des¯urane anaesthesia was associated
with a signi®cant interindividual variability, with a ten-
dency to aggravation of bronchoconstriction.
Methodological issues
In accordance with previous studies,21 22 repeated sensitiza-
tion with ovalbumin induced BHR in response to MCh and
resulted in an antigen±antibody reaction with severe lung
constriction. The total number of leucocytes in the BAL
¯uid collected from the sensitized animals was signi®cantly
higher than that in the control animals, indicating that
airway in¯ammation was induced by airway sensitization.
This model of BHR was chosen because it mimics the
clinical situation where anaesthetists must meet the chal-
lenge of the management of patients with bronchial
in¯ammatory disease leading to hyperreactive airways.
Direct stimulation of the muscarinic receptors is frequent
in clinical practice, particularly during tracheal intubation or
mechanical stimulation of the airways (i.e. bronchoscopy or
bronchial suction). The muscarinic receptors can also be
activated following acetylcholine liberation via vagal
stimulation (i.e. surgical stimulation under light anaesthesia,
and manipulation of the upper airways). Accordingly, MCh
was chosen to mimic these situations encountered in clinical
practice. Moreover, since identi®cation of airway behaviour
following muscarinic stimulation is of primary interest for
anaesthetists, the i.v. administration of MCh was chosen
because this route has been shown to lead primarily to
bronchoconstriction in small rodents without alterations in
the viscoelastic properties of the lung parenchyma.12 17 18 In
agreement with our previous ®ndings in rats,12 17 i.v. MCh
infusion also predominantly induces airway constriction in
this animal model. The moderate increases in G observed in
the present study without signi®cant changes in H re¯ect
enhanced ventilation heterogeneities.18
As most previous studies used global parameters to
characterize the lung responses to volatile anaesthetic
agents,3 4 6±9 13 the relative contributions of the airways
and the parenchyma to the lung response cannot be
distinguished. In the present study, forced oscillatory
impedance data were used to separate airway and parench-
ymal mechanics. This technique has been validated17 18 and
applied successfully in small rodents.12 19 20 The impedance
data obtained in the present study are in good qualitative
agreement with those measured in various
mammals,10 12 15±18 and are similar to the ZL data obtained
previously in guinea pigs.19 20 Furthermore, the comparable
lung mechanical parameters under baseline conditions in the
controls and sensitized guinea pigs con®rm the previous
®nding that sensitization does not alter baseline lung
mechanics, affecting only airway responsiveness to con-
strictor stimuli.22
Effects of volatile agents
This is the ®rst study demonstrating a temporal change after
the administration of volatile agents in the presence of
sustained airway constriction in an animal model of BHR.
All the volatile agents tested exerted a bronchodilatory
effect, with different magnitudes and timings, which
gradually declined with time.
Iso¯urane had the most potent bronchodilatory effect, and
lasted longest among the agents studied at comparable
alveolar concentrations. This potential of iso¯urane to
reverse bronchoconstriction is in accordance with previous
clinical and experimental observations.7±9
After the very transient decreases in Raw observed at 1
min with des¯urane, this volatile agent induced highly
variable changes in Raw, with a mean increase of approxi-
mately 20%. This ®nding con®rms recent results by Goff
and colleagues,27 which demonstrated a signi®cant broncho-
constriction in patients with BHR when des¯urane was
administered after tracheal intubation.
The bronchodilatory effect vanished in the second phase
of volatile agent administration; indeed, further increases in
Raw were observed. This effect was the most noteworthy
for halothane and sevo¯urane, whereas the deep initial
Fig 3 Changes in tissue elastance (H) during volatile agent
administration. Values (mean and SE) are represented as relative changes
from the plateau constriction induced by the continuous infusion of
methacholine (MCh).
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decrease in Raw during iso¯urane administration led to
signi®cant increases only at the end of the administration
period. Since the end-tidal concentration of volatile agent
was monitored continuously and the vaporizer was adjusted
accordingly, stable anaesthetic levels were guaranteed.
Furthermore, the instability of a sustained MCh infusion is
not responsible for this ®nding either, since MCh induced
stable increases in Raw in the guinea pigs receiving no
volatile anaesthetic (Fig. 1). To explain the decline in the
bronchodilatory potential of the volatile agents, the mech-
anisms of their action on the tracheobronchial tree needs to
be considered.
The direct effect of volatile anaesthetics on airway
smooth muscle can be excluded, since the constrictor effects
of the volatile agents would be expected to decline once
their administration is terminated. Since the bronchodilatory
capabilities of volatile agents on the distal bronchi are
mediated by the epithelium,28 epithelial damage induced by
sensitization29 may have altered epithelial function, leading
to the lack of a persistent bronchodilation. Augmentation of
in¯ammatory reactions in the sensitized airways caused by
volatile anaesthetics30 may have also led to the increases
observed in Raw. However, this phenomenon was not likely
to play a major role, since our additional experiments in
animals with normal and hyperreactive airways revealed
similar effects of volatile anaesthetics on basal airway tone
(0.3 (4.4)% vs 7.0 (5.7)% decrease in Raw 10 min after
iso¯urane administration in the control and sensitized
guinea pigs, respectively; P=0.33). To induce liberation of
pro-in¯ammatory cytokines by volatile agents in animals
with hyperreactive airways, a longer period of inhalation
anaesthesia and mechanical ventilation may be necessary.30
The indirect effects of the volatile agents, such as
involvement of neural or humoral pathways or interactions
between pulmonary haemodynamics and airway mechanics,
may also have contributed to the decline in bronchodilatory
potential. To clarify the role of altered haemodynamics, it is
noteworthy that there were no statistically signi®cant
additional changes in haemodynamic parameters (arterial
pressure and heart rate) after introduction of the volatile
agents (data not shown), which makes it unlikely that this
mechanism contributed to the elevations in Raw. To
investigate the potential role of the vagus, further experi-
ments in another group of sensitized, vagotomized guinea
pigs also revealed the same biphasic changes in Raw (data
not shown). This ®nding suggests that vagal re¯exes are not
responsible for this phenomenon. Thus, other indirect
mechanisms via either the non-adrenergic non-cholinergic
neural pathway or release of different bronchoactive
humoral mediators, or both, may have gradually overcome
the direct dilatory effects of the volatile agents.31 To
identify the underlying mechanisms, further experiments
involving the use of different blocking agents in a large
number of animals would be required and would be a
subject of subsequent investigations.
Summary and conclusions
Volatile agents exert a potent bronchodilatory effect in
providing protection against constrictor stimuli. The present
study demonstrated that inhalational anaesthetics exhibit
only a transient dilatory activity in the presence of a
sustained constriction in an experimental model of bron-
chial hyperreactivity. Iso¯urane was found to be the most
effective in decreasing elevated airway tone, whereas
des¯urane displayed a potential to induce further airway
constriction. Prolonged administration of all volatile agents
led to a decline in bronchodilatory potential via indirect
effects. These ®ndings con®rm the advantage of iso¯urane
in the presence of bronchospasm and the potential risk of a
further increase in airway tone when des¯urane is admin-
istered to hyperreactive airways.
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